Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Post-inflammatory retinal dystrophy in CINCA syndrome.

Literature DB >> 19424698

Post-inflammatory retinal dystrophy in CINCA syndrome.

Donato Rigante¹, Achille Stabile, Angelo Minnella, Laura Avallone, Lucia Ziccardi, Giulia Bersani, Giovanna Stifano, Adele Compagnone, Benedetto Falsini.

Abstract

Right chorioretinitis and bilateral pseudopapilledema were firstly appreciated in a 9-month-old child with neonatal findings of aseptic chronic meningitis, framed in the context of CINCA syndrome at 1 year. Therapeutical response to various combinations of drugs was inconsistent until 7 years, when anakinra was started with immediate clinical and laboratory improvement. A state of severe retinal dystrophy of post-inflammatory origin became evident on funduscopy, optical coherence tomography and visual electrophysiology tests at the age of 10 years, which remained stationary after 1 year of anakinra treatment.

Entities: Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19424698 DOI： 10.1007/s00296-009-0939-y

Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631

21 in total

1. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome.

Authors: S C B Teoh; S Sharma; A Hogan; R Lee; A V Ramanan; A D Dick
Journal: Br J Ophthalmol Date: 2007-02 Impact factor: 4.638

2. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors: C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal: Nature Date: 1990-01-25 Impact factor: 49.962

Review 3. Congenital cytomegalovirus infection and disease.

Authors: G J Demmler
Journal: Adv Pediatr Infect Dis Date: 1996

4. Recognition of infantile-onset multisystem inflammatory disease as a unique entity.

Authors: P J Hashkes; D J Lovell
Journal: J Pediatr Date: 1997-04 Impact factor: 4.406

5. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene.

Authors: Tadashi Matsubayashi; Hiroshi Sugiura; Takashi Arai; Tsutomu Oh-Ishi; Yasuji Inamo
Journal: Acta Paediatr Date: 2006-02 Impact factor: 2.299

6. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors: S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal: N Engl J Med Date: 2001-05-03 Impact factor: 91.245

7. Chronic infantile neurological cutaneous articular syndrome in a patient from Japan.

Authors: M Miura; T Okabe; S Tsubata; N Takizawa; T Sawaguchi
Journal: Eur J Pediatr Date: 1997-08 Impact factor: 3.183

8. Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience.

Authors: A Stabile; L Avallone; A Compagnone; V Ansuini; B Bertoni; D Rigante
Journal: Eur Rev Med Pharmacol Sci Date: 2006 Sep-Oct Impact factor: 3.507

9. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood.

Authors: H Dollfus; R Häfner; H M Hofmann; R A Russo; L Denda; L D Gonzales; C DeCunto; J Premoli; J Melo-Gomez; J P Jorge; R Vesely; M Stubna; J L Dufier; A M Prieur
Journal: Arch Ophthalmol Date: 2000-10

10. Structure-function relationship in ocular hypertension and glaucoma: interindividual and interocular analysis by OCT and pattern ERG.

Authors: Benedetto Falsini; Dario Marangoni; Tommaso Salgarello; Giovanna Stifano; Lucrezia Montrone; Francesca Campagna; Stefania Aliberti; Emilio Balestrazzi; Alberto Colotto
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-04-02 Impact factor: 3.117

7 in total

Review 1. NLRs in immune privileged sites.

Authors: Holly L Rosenzweig; Stephen R Planck; James T Rosenbaum
Journal: Curr Opin Pharmacol Date: 2011-07-29 Impact factor: 5.547

Review 2. The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors: Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal: Clin Rheumatol Date: 2015-04-02 Impact factor: 2.980

Review 3. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.

Authors: Raphaela Goldbach-Mansky
Journal: Curr Rheumatol Rep Date: 2011-04 Impact factor: 4.592

Review 4. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Authors: Claudia Fabiani; Jurgen Sota; Gian Marco Tosi; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Luca Cantarini
Journal: Clin Rheumatol Date: 2016-12-28 Impact factor: 2.980

5. Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra.

Authors: Celine Terrada; Benedicte Neven; Nathalie Boddaert; Eric H Souied; Anne Marie Prieur; Pierre Quartier; Phuc Lehoang; Bahram Bodaghi
Journal: J Ophthalmic Inflamm Infect Date: 2011-04-09

Review 6. Ocular involvement in primary immunodeficiency diseases.

Authors: Sima Hosseinverdi; Hassan Hashemi; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal: J Clin Immunol Date: 2013-11-30 Impact factor: 8.542

Review 7. Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Authors: Carla Gaggiano; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Alessandra Fabbiani; Giovanna Capozio; Chiara Marzo; Viviana Gelardi; Salvatore Grosso; Bruno Frediani; Alessandra Renieri; Luca Cantarini
Journal: Mediators Inflamm Date: 2019-12-31 Impact factor: 4.711

7 in total